Literature DB >> 25502626

Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility.

Rose McDonnell1, Jane Marjoribanks, Roger J Hart.   

Abstract

BACKGROUND: Ten per cent to 15% of couples have difficulty in conceiving. A proportion of these couples will ultimately require assisted reproduction. Prior to controlled ovarian hyperstimulation (COH) a baseline ultrasound is performed to detect the presence of ovarian cysts.Previous research has suggested that there is a relationship between the presence of an ovarian cyst prior to COH and poor outcome during IVF.
OBJECTIVES: The aim of this review was to determine the effectiveness and safety of functional ovarian cyst aspiration prior to ovarian stimulation versus a conservative approach in women with an ovarian cyst who were undergoing IVF or ICSI. SEARCH
METHODS: We searched the Menstrual Disorders and Subfertility Group (MDSG) Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO, CINAHL, ClinicalTrials.gov, Google Scholar and PubMed. The evidence was current to April 2014 and no language restrictions were applied. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) comparing functional ovarian cyst aspiration versus conservative management of ovarian cysts that have been seen on transvaginal ultrasound (TVS) prior to COH for IVF or ICSI. Ovarian cysts were defined as simple, functional ovarian cysts > 20 mm in diameter. Oocyte donors and women undergoing donor oocyte cycles were excluded. DATA COLLECTION AND ANALYSIS: Study selection, data extraction and risk of bias assessments were conducted independently by two review authors. The primary outcome measures were live birth rate and adverse events. The overall quality of the evidence for each comparison was rated using GRADE methods. MAIN
RESULTS: Three studies were eligible for inclusion (n = 339), all of which used agonist protocols. Neither live birth rate nor adverse events were reported by any of the included studies. There was no conclusive evidence of a difference between the group who underwent ovarian cyst aspiration and the conservatively managed group in the clinical pregnancy rate (OR 1.40, 95% CI 0.67 to 2.94, 3 studies, 339 women, I(2) = 0%, low quality evidence). This suggested that if the clinical pregnancy rate in women with conservative management was assumed to be 5%, the chance following cyst aspiration would be between 4% and 14%. There was no evidence of a difference between the groups in the mean number of follicles recruited (0.55 follicles, 95% CI -0.48 to 1.59, 2 studies, 159 women, I(2) = 0%, low quality evidence) or mean number of oocytes collected (0.41 oocytes, 95% CI -0.04 to 0.85, 3 studies, 339 women, I(2) = 0%, low quality evidence). Findings for the cancellation rate (two studies) were inconsistent but neither study reported a benefit for the aspiration group. The main limitations of the evidence were imprecision, inconsistency, questionable applicability, and poor reporting of study methods. AUTHORS'
CONCLUSIONS: There is insufficient evidence to determine whether drainage of functional ovarian cysts prior to controlled ovarian hyperstimulation influences live birth rate, clinical pregnancy rate, number of follicles recruited, or oocytes collected in women with a functional ovarian cyst. The findings of this review do not provide supportive evidence for this approach, particularly in view of the requirement for anaesthesia, extra cost, psychological stress and risk of surgical complications.

Entities:  

Mesh:

Year:  2014        PMID: 25502626      PMCID: PMC6483607          DOI: 10.1002/14651858.CD005999.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  21 in total

1.  Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome.

Authors:  M D Keltz; E E Jones; A J Duleba; T Polcz; K Kennedy; D L Olive
Journal:  Fertil Steril       Date:  1995-09       Impact factor: 7.329

Review 2.  Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.

Authors:  Hesham G Al-Inany; Mohamed Afm Youssef; Mohamed Aboulghar; Frank Broekmans; Monique Sterrenburg; Janine Smit; Ahmed M Abou-Setta
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

Review 3.  Relationship between ovarian cysts and infertility: what surgery and when?

Authors:  Guillaume Legendre; Laurent Catala; Catherine Morinière; Céline Lacoeuille; Françoise Boussion; Loïc Sentilhes; Philippe Descamps
Journal:  Fertil Steril       Date:  2014-03       Impact factor: 7.329

4.  The effects of baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program.

Authors:  M D Hornstein; R L Barbieri; V A Ravnikar; P M McShane
Journal:  Fertil Steril       Date:  1989-09       Impact factor: 7.329

5.  Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction.

Authors:  G E Fiszbajn; R G Lipowicz; L Elberger; A Grabia; S D Papier; S P Brugo Olmedo; C F Chillik
Journal:  J Assist Reprod Genet       Date:  2000-05       Impact factor: 3.412

6.  Aspiration cytology of ovarian cysts in in vitro fertilization patients.

Authors:  E Greenebaum; J R Mayer; J J Stangel; P Hughes
Journal:  Acta Cytol       Date:  1992 Jan-Feb       Impact factor: 2.319

7.  The development of functional ovarian cysts during pituitary down-regulation.

Authors:  J M Jenkins; F W Anthony; P Wood; D Rushen; G M Masson; E Thomas
Journal:  Hum Reprod       Date:  1993-10       Impact factor: 6.918

8.  Ovarian cyst aspiration during in vitro fertilization/embryo transfer (IVF/ET) cycles.

Authors:  D Feldberg; J Ashkenazi; D Dicker; A Yeshaya; I Voliovitch; J A Goldman
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-12

9.  Management of prestimulation ovarian cysts during assisted reproductive treatments: impact of aspiration on the outcome.

Authors:  Banu Kumbak; Semra Kahraman
Journal:  Arch Gynecol Obstet       Date:  2008-11-21       Impact factor: 2.344

Review 10.  GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET).

Authors:  Raffaella Depalo; K Jayakrishan; Gabriella Garruti; Ilaria Totaro; Mariantonietta Panzarino; Francesco Giorgino; Luigi E Selvaggi
Journal:  Reprod Biol Endocrinol       Date:  2012-04-13       Impact factor: 5.211

View more
  6 in total

1.  Assisted reproductive technology: an overview of Cochrane Reviews.

Authors:  Cindy Farquhar; Jane Marjoribanks
Journal:  Cochrane Database Syst Rev       Date:  2018-08-17

Review 2.  Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.

Authors:  Selma Mourad; Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2017-01-23

3.  HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study.

Authors:  Hong Zeng; Chen Zhang; Lei Zhang; Nenghui Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

Review 4.  Effects of ovarian endometrioma aspiration on in vitro fertilization-intracytoplasmic sperm injection and embryo transfer outcomes: a systematic review and meta-analysis.

Authors:  Xinyan Gao; Yousheng Zhang; Xinxin Xu; Shaoming Lu; Lei Yan
Journal:  Arch Gynecol Obstet       Date:  2021-11-08       Impact factor: 2.493

5.  Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.

Authors:  Hui Ji; Yan Su; Mianqiu Zhang; Xin Li; Xiuling Li; Hui Ding; Li Dong; Shanren Cao; Chun Zhao; Junqiang Zhang; Rong Shen; Xiufeng Ling
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

6.  Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study.

Authors:  Yingfen Ying; Tanchu Yang; Huina Zhang; Chang Liu; Junzhao Zhao
Journal:  PeerJ       Date:  2019-04-29       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.